Showing results 24536 to 24555 of 104258
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 2009 | Cyclosporine withdrawal improves long-term graft survival in renal transplantation | Gallagher, M.; Jardine, M.; Perkovic, V.; Cass, A.; McDonald, S.; Petrie, J.; Eris, J. |
| 2020 | CYLD is a causative gene for frontotemporal dementia - amyotrophic lateral sclerosis | Dobson-Stone, C.; Hallupp, M.; Shahheydari, H.; Ragagnin, A.M.G.; Chatterton, Z.; Carew-Jones, F.; Shepherd, C.E.; Stefen, H.; Paric, E.; Fath, T.; Thompson, E.M.; Blumbergs, P.; Short, C.L.; Field, C.D.; Panegyres, P.K.; Hecker, J.; Nicholson, G.; Shaw, A.D.; Fullerton, J.M.; Luty, A.A.; et al. |
| 2001 | Cylindrical and conical electrostatic wobble micromotors | Sarros, A.; Chew, E.; Crase, S.; Tay, B.; Soong, W.; Abbott, D.; Varadan, V.; Boehringer, K.; Smart Electronics and MEMS II (2000 : Melbourne, Australia) |
| 2014 | Cylindrical RF network antennas for coupled plasma sources copper legs delayed in time system stability analysis | Aluf, O. |
| 2005 | Cylindrospermopsin genotoxicity and cytotoxicity: Role of cytochrome P-450 and oxidative stress | Humpage, A.; Fontaine, F.; Froscio, S.; Burcham, P.; Falconer, I. |
| 2003 | Cylindrospermopsin occurrence in two German lakes and preliminary assessment of toxicity and toxin production of Cylindrospermopsis raciborskii (Cyanobacteria) isolates | Fastner, J.; Heinze, R.; Humpage, A.; Mischke, U.; Eaglesham, G.; Chorus, I. |
| 2012 | Cylindrospermopsin, a blue-green algal toxin, inhibited human luteinised granulosa cell protein synthesis in vitro | Young, F.; Zebian, D.; Froscio, S.; Humpage, A. |
| 2003 | Cylindrospermopsin-induced protein synthesis inhibition and its dissociation from acute toxicity in mouse hepatocytes | Froscio, S.; Humpage, A.; Burcham, P.; Falconer, I. |
| 2023 | Cymredoxin, a [2Fe–2S] ferredoxin, supports catalytic activity of the p-cymene oxidising P450 enzyme CYP108N12 | Giang, P.D.; Churchman, L.R.; Stok, J.E.; Bell, S.G.; De Voss, J.J. |
| 2016 | Cynicism and other attitudes towards patients in an emergency department in a middle eastern tertiary care center | Batley, N.; Nasreddine, Z.; Chami, A.; Zebian, D.; Bachir, R.; Abbas, H. |
| 2005 | CYP gene expression profiling in the mouse male germ line | Schjenken, J.; Aitken, R.; Roman, S.; Annual Meeting of the United Kingdom Environmental Mutagen Society (28th : 2005 : Bradford, UK) |
| 2015 | CYP-mediated drug-drug interactions with evacetrapib, an investigational CETP inhibitor: in vitro prediction and clinical outcome | Cannady, E.; Suico, J.; Wang, M.; Friedrich, S.; Rehmel, J.; Nicholls, S.; Krueger, K. |
| 2024 | CYP108N14: A Monoterpene Monooxygenase from Rhodococcus globerulus | Giang, P.D.; Churchman, L.R.; Buczynski, J.B.; Bell, S.G.; Stok, J.E.; De Voss, J.J. |
| 2015 | CYP199A4 catalyses the efficient demethylation and demethenylation of para-substituted benzoic acid derivatives | Coleman, T.; Chao, R.; Bruning, J.; De Voss, J.; Bell, S. |
| 2007 | CYP2B6 CYP2D6 and CYP3A4 catalyze the primary oxidative metabolism of perhexiline enantiomers by human liver microsomes | Davies, B.; Coller, J.; Somogyi, A.; Milne, R.; Sallustio, B. |
| 2015 | CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects | Li, Y.; Jackson, K.; Slon, B.; Hardy, J.; Franco, M.; William, L.; Poon, P.; Coller, J.; Hutchinson, M.; Currow, D.; Somogyi, A. |
| 2013 | CYP2C19*2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment | Beelen, K.; Opdam, M.; Severson, T.; Koornstra, R.; Vincent, A.; Hauptmann, M.; Van Schaik, R.; Berns, E.; Vermorken, J.; Van Diest, P.; Linn, S. |
| 2017 | CYP2C8 genotype significantly alters imatinib metabolism in chronic myeloid leukaemia patients | Barratt, D.; Cox, H.; Menelaou, A.; Yeung, D.; White, D.; Hughes, T.; Somogyi, A. |
| 2004 | CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes | Hutchinson, M.; Menelaou, A.; Foster, D.; Coller, J.; Somogyi, A. |
| 2010 | CYP2D6 polymorphisms as predictors of outcome in breast cancer patients treated with tamoxifen: Expanded polymorphism coverage improves risk stratification | Schroth, W.; Hamann, U.; Fasching, P.; Dauser, S.; Winter, S.; Eichelbaum, M.; Schwab, M.; Brauch, H. |
